Emcure Pharmaceuticals Announces Strong Q2FY25 with 20% Revenue Growth and 38% Profit After Tax Growth

07.11.2024

Emcure Pharma Strengthens its Derma Portfolio with the launch of Emcutix Biopharmaceuticals Limited

28.10.2024

Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir

03.10.2024

Emcure Pharmaceuticals Announces Strong Q1FY25 Results with 17% Revenue Growth and 16% EBITDA Growth

13.08.2024

Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power.

25.07.2024